r5/resource_types/specialized/medication_definition/medication_definition
library
Classes
-
AdministrableProductDefinition
-
AdministrableProductDefinition A medicinal product in the final form
which is suitable for administering to a patient (after any mixing of
multiple components, dissolution etc. has been performed).
-
AdministrableProductDefinitionProperty
-
AdministrableProductDefinitionProperty A medicinal product in the final
form which is suitable for administering to a patient (after any mixing of
multiple components, dissolution etc. has been performed).
-
AdministrableProductDefinitionRouteOfAdministration
-
AdministrableProductDefinitionRouteOfAdministration A medicinal product
in the final form which is suitable for administering to a patient (after
any mixing of multiple components, dissolution etc. has been performed).
-
AdministrableProductDefinitionTargetSpecies
-
AdministrableProductDefinitionTargetSpecies A medicinal product in the
final form which is suitable for administering to a patient (after any
mixing of multiple components, dissolution etc. has been performed).
-
AdministrableProductDefinitionWithdrawalPeriod
-
AdministrableProductDefinitionWithdrawalPeriod A medicinal product in the
final form which is suitable for administering to a patient (after any
mixing of multiple components, dissolution etc. has been performed).
-
ClinicalUseDefinition
-
ClinicalUseDefinition A single issue - either an indication,
contraindication, interaction or an undesirable effect for a medicinal
product, medication, device or procedure.
-
ClinicalUseDefinitionContraindication
-
ClinicalUseDefinitionContraindication A single issue - either an
indication, contraindication, interaction or an undesirable effect for a
medicinal product, medication, device or procedure.
-
ClinicalUseDefinitionIndication
-
ClinicalUseDefinitionIndication A single issue - either an indication,
contraindication, interaction or an undesirable effect for a medicinal
product, medication, device or procedure.
-
ClinicalUseDefinitionInteractant
-
ClinicalUseDefinitionInteractant A single issue - either an indication,
contraindication, interaction or an undesirable effect for a medicinal
product, medication, device or procedure.
-
ClinicalUseDefinitionInteraction
-
ClinicalUseDefinitionInteraction A single issue - either an indication,
contraindication, interaction or an undesirable effect for a medicinal
product, medication, device or procedure.
-
ClinicalUseDefinitionOtherTherapy
-
ClinicalUseDefinitionOtherTherapy A single issue - either an indication,
contraindication, interaction or an undesirable effect for a medicinal
product, medication, device or procedure.
-
ClinicalUseDefinitionUndesirableEffect
-
ClinicalUseDefinitionUndesirableEffect A single issue - either an
indication, contraindication, interaction or an undesirable effect for a
medicinal product, medication, device or procedure.
-
ClinicalUseDefinitionWarning
-
ClinicalUseDefinitionWarning A single issue - either an indication,
contraindication, interaction or an undesirable effect for a medicinal
product, medication, device or procedure.
-
Ingredient
-
Ingredient An ingredient of a manufactured item or pharmaceutical product.
-
IngredientManufacturer
-
IngredientManufacturer An ingredient of a manufactured item or
pharmaceutical product.
-
IngredientReferenceStrength
-
IngredientReferenceStrength An ingredient of a manufactured item or
pharmaceutical product.
-
IngredientStrength
-
IngredientStrength An ingredient of a manufactured item or pharmaceutical
product.
-
IngredientSubstance
-
IngredientSubstance An ingredient of a manufactured item or
pharmaceutical product.
-
ManufacturedItemDefinition
-
ManufacturedItemDefinition The definition and characteristics of a
medicinal manufactured item, such as a tablet or capsule, as contained in
a packaged medicinal product.
-
ManufacturedItemDefinitionComponent
-
ManufacturedItemDefinitionComponent The definition and characteristics of
a medicinal manufactured item, such as a tablet or capsule, as contained
in a packaged medicinal product.
-
ManufacturedItemDefinitionConstituent
-
ManufacturedItemDefinitionConstituent The definition and characteristics
of a medicinal manufactured item, such as a tablet or capsule, as
contained in a packaged medicinal product.
-
ManufacturedItemDefinitionProperty
-
ManufacturedItemDefinitionProperty The definition and characteristics of
a medicinal manufactured item, such as a tablet or capsule, as contained
in a packaged medicinal product.
-
MedicinalProductDefinition
-
MedicinalProductDefinition A medicinal product, being a substance or
combination of substances that is intended to treat, prevent or diagnose a
disease, or to restore, correct or modify physiological functions by
exerting a pharmacological, immunological or metabolic action. This
resource is intended to define and detail such products and their
properties, for uses other than direct patient care (e.g. regulatory use,
or drug catalogs).
-
MedicinalProductDefinitionCharacteristic
-
MedicinalProductDefinitionCharacteristic A medicinal product, being a
substance or combination of substances that is intended to treat, prevent
or diagnose a disease, or to restore, correct or modify physiological
functions by exerting a pharmacological, immunological or metabolic
action. This resource is intended to define and detail such products and
their properties, for uses other than direct patient care (e.g. regulatory
use, or drug catalogs).
-
MedicinalProductDefinitionContact
-
MedicinalProductDefinitionContact A medicinal product, being a substance
or combination of substances that is intended to treat, prevent or
diagnose a disease, or to restore, correct or modify physiological
functions by exerting a pharmacological, immunological or metabolic
action. This resource is intended to define and detail such products and
their properties, for uses other than direct patient care (e.g. regulatory
use, or drug catalogs).
-
MedicinalProductDefinitionCrossReference
-
MedicinalProductDefinitionCrossReference A medicinal product, being a
substance or combination of substances that is intended to treat, prevent
or diagnose a disease, or to restore, correct or modify physiological
functions by exerting a pharmacological, immunological or metabolic
action. This resource is intended to define and detail such products and
their properties, for uses other than direct patient care (e.g. regulatory
use, or drug catalogs).
-
MedicinalProductDefinitionName
-
MedicinalProductDefinitionName A medicinal product, being a substance or
combination of substances that is intended to treat, prevent or diagnose a
disease, or to restore, correct or modify physiological functions by
exerting a pharmacological, immunological or metabolic action. This
resource is intended to define and detail such products and their
properties, for uses other than direct patient care (e.g. regulatory use,
or drug catalogs).
-
MedicinalProductDefinitionOperation
-
MedicinalProductDefinitionOperation A medicinal product, being a
substance or combination of substances that is intended to treat, prevent
or diagnose a disease, or to restore, correct or modify physiological
functions by exerting a pharmacological, immunological or metabolic
action. This resource is intended to define and detail such products and
their properties, for uses other than direct patient care (e.g. regulatory
use, or drug catalogs).
-
MedicinalProductDefinitionPart
-
MedicinalProductDefinitionPart A medicinal product, being a substance or
combination of substances that is intended to treat, prevent or diagnose a
disease, or to restore, correct or modify physiological functions by
exerting a pharmacological, immunological or metabolic action. This
resource is intended to define and detail such products and their
properties, for uses other than direct patient care (e.g. regulatory use,
or drug catalogs).
-
MedicinalProductDefinitionUsage
-
MedicinalProductDefinitionUsage A medicinal product, being a substance or
combination of substances that is intended to treat, prevent or diagnose a
disease, or to restore, correct or modify physiological functions by
exerting a pharmacological, immunological or metabolic action. This
resource is intended to define and detail such products and their
properties, for uses other than direct patient care (e.g. regulatory use,
or drug catalogs).
-
PackagedProductDefinition
-
PackagedProductDefinition A medically related item or items, in a
container or package.
-
PackagedProductDefinitionContainedItem
-
PackagedProductDefinitionContainedItem A medically related item or items,
in a container or package.
-
PackagedProductDefinitionLegalStatusOfSupply
-
PackagedProductDefinitionLegalStatusOfSupply A medically related item or
items, in a container or package.
-
PackagedProductDefinitionPackaging
-
PackagedProductDefinitionPackaging A medically related item or items, in
a container or package.
-
PackagedProductDefinitionProperty
-
PackagedProductDefinitionProperty A medically related item or items, in a
container or package.
-
RegulatedAuthorization
-
RegulatedAuthorization Regulatory approval, clearance or licencing
related to a regulated product, treatment, facility or activity that is
cited in a guidance, regulation, rule or legislative act. An example is
Market Authorization relating to a Medicinal Product.
-
RegulatedAuthorizationCase
-
RegulatedAuthorizationCase Regulatory approval, clearance or licencing
related to a regulated product, treatment, facility or activity that is
cited in a guidance, regulation, rule or legislative act. An example is
Market Authorization relating to a Medicinal Product.
-
SubstanceDefinition
-
SubstanceDefinition The detailed description of a substance, typically at
a level beyond what is used for prescribing.
-
SubstanceDefinitionCharacterization
-
SubstanceDefinitionCharacterization The detailed description of a
substance, typically at a level beyond what is used for prescribing.
-
SubstanceDefinitionCode
-
SubstanceDefinitionCode The detailed description of a substance,
typically at a level beyond what is used for prescribing.
-
SubstanceDefinitionMoiety
-
SubstanceDefinitionMoiety The detailed description of a substance,
typically at a level beyond what is used for prescribing.
-
SubstanceDefinitionMolecularWeight
-
SubstanceDefinitionMolecularWeight The detailed description of a
substance, typically at a level beyond what is used for prescribing.
-
SubstanceDefinitionName
-
SubstanceDefinitionName The detailed description of a substance,
typically at a level beyond what is used for prescribing.
-
SubstanceDefinitionOfficial
-
SubstanceDefinitionOfficial The detailed description of a substance,
typically at a level beyond what is used for prescribing.
-
SubstanceDefinitionProperty
-
SubstanceDefinitionProperty The detailed description of a substance,
typically at a level beyond what is used for prescribing.
-
SubstanceDefinitionRelationship
-
SubstanceDefinitionRelationship The detailed description of a substance,
typically at a level beyond what is used for prescribing.
-
SubstanceDefinitionRepresentation
-
SubstanceDefinitionRepresentation The detailed description of a
substance, typically at a level beyond what is used for prescribing.
-
SubstanceDefinitionSourceMaterial
-
SubstanceDefinitionSourceMaterial The detailed description of a
substance, typically at a level beyond what is used for prescribing.
-
SubstanceDefinitionStructure
-
SubstanceDefinitionStructure The detailed description of a substance,
typically at a level beyond what is used for prescribing.
-
SubstanceNucleicAcid
-
SubstanceNucleicAcid Nucleic acids are defined by three distinct
elements: the base, sugar and linkage. Individual substance/moiety IDs
will be created for each of these elements. The nucleotide sequence will
be always entered in the 5’-3’ direction.
-
SubstanceNucleicAcidLinkage
-
SubstanceNucleicAcidLinkage Nucleic acids are defined by three distinct
elements: the base, sugar and linkage. Individual substance/moiety IDs
will be created for each of these elements. The nucleotide sequence will
be always entered in the 5’-3’ direction.
-
SubstanceNucleicAcidSubunit
-
SubstanceNucleicAcidSubunit Nucleic acids are defined by three distinct
elements: the base, sugar and linkage. Individual substance/moiety IDs
will be created for each of these elements. The nucleotide sequence will
be always entered in the 5’-3’ direction.
-
SubstanceNucleicAcidSugar
-
SubstanceNucleicAcidSugar Nucleic acids are defined by three distinct
elements: the base, sugar and linkage. Individual substance/moiety IDs
will be created for each of these elements. The nucleotide sequence will
be always entered in the 5’-3’ direction.
-
SubstancePolymer
-
SubstancePolymer Properties of a substance specific to it being a polymer.
-
SubstancePolymerDegreeOfPolymerisation
-
SubstancePolymerDegreeOfPolymerisation Properties of a substance specific
to it being a polymer.
-
SubstancePolymerMonomerSet
-
SubstancePolymerMonomerSet Properties of a substance specific to it being
a polymer.
-
SubstancePolymerRepeat
-
SubstancePolymerRepeat Properties of a substance specific to it being a
polymer.
-
SubstancePolymerRepeatUnit
-
SubstancePolymerRepeatUnit Properties of a substance specific to it being
a polymer.
-
SubstancePolymerStartingMaterial
-
SubstancePolymerStartingMaterial Properties of a substance specific to it
being a polymer.
-
SubstancePolymerStructuralRepresentation
-
SubstancePolymerStructuralRepresentation Properties of a substance
specific to it being a polymer.
-
SubstanceProtein
-
SubstanceProtein A SubstanceProtein is defined as a single unit of a
linear amino acid sequence, or a combination of subunits that are either
covalently linked or have a defined invariant stoichiometric relationship.
This includes all synthetic, recombinant and purified SubstanceProteins of
defined sequence, whether the use is therapeutic or prophylactic. This set
of elements will be used to describe albumins, coagulation factors,
cytokines, growth factors, peptide/SubstanceProtein hormones, enzymes,
toxins, toxoids, recombinant vaccines, and immunomodulators.
-
SubstanceProteinSubunit
-
SubstanceProteinSubunit A SubstanceProtein is defined as a single unit of
a linear amino acid sequence, or a combination of subunits that are either
covalently linked or have a defined invariant stoichiometric relationship.
This includes all synthetic, recombinant and purified SubstanceProteins of
defined sequence, whether the use is therapeutic or prophylactic. This set
of elements will be used to describe albumins, coagulation factors,
cytokines, growth factors, peptide/SubstanceProtein hormones, enzymes,
toxins, toxoids, recombinant vaccines, and immunomodulators.
-
SubstanceReferenceInformation
-
SubstanceReferenceInformation
-
SubstanceReferenceInformationGene
-
SubstanceReferenceInformationGene
-
SubstanceReferenceInformationGeneElement
-
SubstanceReferenceInformationGeneElement
-
SubstanceReferenceInformationTarget
-
SubstanceReferenceInformationTarget
-
SubstanceSourceMaterial
-
SubstanceSourceMaterial Source material shall capture information on the
taxonomic and anatomical origins as well as the fraction of a material
that can result in or can be modified to form a substance. This set of
data elements shall be used to define polymer substances isolated from
biological matrices. Taxonomic and anatomical origins shall be described
using a controlled vocabulary as required. This information is captured
for naturally derived polymers ( . starch) and structurally diverse
substances. For Organisms belonging to the Kingdom Plantae the Substance
level defines the fresh material of a single species or infraspecies, the
Herbal Drug and the Herbal preparation. For Herbal preparations, the
fraction information will be captured at the Substance information level
and additional information for herbal extracts will be captured at the
Specified Substance Group 1 information level. See for further explanation
the Substance Class: Structurally Diverse and the herbal annex.
-
SubstanceSourceMaterialAuthor
-
SubstanceSourceMaterialAuthor Source material shall capture information
on the taxonomic and anatomical origins as well as the fraction of a
material that can result in or can be modified to form a substance. This
set of data elements shall be used to define polymer substances isolated
from biological matrices. Taxonomic and anatomical origins shall be
described using a controlled vocabulary as required. This information is
captured for naturally derived polymers ( . starch) and structurally
diverse substances. For Organisms belonging to the Kingdom Plantae the
Substance level defines the fresh material of a single species or
infraspecies, the Herbal Drug and the Herbal preparation. For Herbal
preparations, the fraction information will be captured at the Substance
information level and additional information for herbal extracts will be
captured at the Specified Substance Group 1 information level. See for
further explanation the Substance Class: Structurally Diverse and the
herbal annex.
-
SubstanceSourceMaterialFractionDescription
-
SubstanceSourceMaterialFractionDescription Source material shall capture
information on the taxonomic and anatomical origins as well as the
fraction of a material that can result in or can be modified to form a
substance. This set of data elements shall be used to define polymer
substances isolated from biological matrices. Taxonomic and anatomical
origins shall be described using a controlled vocabulary as required. This
information is captured for naturally derived polymers ( . starch) and
structurally diverse substances. For Organisms belonging to the Kingdom
Plantae the Substance level defines the fresh material of a single species
or infraspecies, the Herbal Drug and the Herbal preparation. For Herbal
preparations, the fraction information will be captured at the Substance
information level and additional information for herbal extracts will be
captured at the Specified Substance Group 1 information level. See for
further explanation the Substance Class: Structurally Diverse and the
herbal annex.
-
SubstanceSourceMaterialHybrid
-
SubstanceSourceMaterialHybrid Source material shall capture information
on the taxonomic and anatomical origins as well as the fraction of a
material that can result in or can be modified to form a substance. This
set of data elements shall be used to define polymer substances isolated
from biological matrices. Taxonomic and anatomical origins shall be
described using a controlled vocabulary as required. This information is
captured for naturally derived polymers ( . starch) and structurally
diverse substances. For Organisms belonging to the Kingdom Plantae the
Substance level defines the fresh material of a single species or
infraspecies, the Herbal Drug and the Herbal preparation. For Herbal
preparations, the fraction information will be captured at the Substance
information level and additional information for herbal extracts will be
captured at the Specified Substance Group 1 information level. See for
further explanation the Substance Class: Structurally Diverse and the
herbal annex.
-
SubstanceSourceMaterialOrganism
-
SubstanceSourceMaterialOrganism Source material shall capture information
on the taxonomic and anatomical origins as well as the fraction of a
material that can result in or can be modified to form a substance. This
set of data elements shall be used to define polymer substances isolated
from biological matrices. Taxonomic and anatomical origins shall be
described using a controlled vocabulary as required. This information is
captured for naturally derived polymers ( . starch) and structurally
diverse substances. For Organisms belonging to the Kingdom Plantae the
Substance level defines the fresh material of a single species or
infraspecies, the Herbal Drug and the Herbal preparation. For Herbal
preparations, the fraction information will be captured at the Substance
information level and additional information for herbal extracts will be
captured at the Specified Substance Group 1 information level. See for
further explanation the Substance Class: Structurally Diverse and the
herbal annex.
-
SubstanceSourceMaterialOrganismGeneral
-
SubstanceSourceMaterialOrganismGeneral Source material shall capture
information on the taxonomic and anatomical origins as well as the
fraction of a material that can result in or can be modified to form a
substance. This set of data elements shall be used to define polymer
substances isolated from biological matrices. Taxonomic and anatomical
origins shall be described using a controlled vocabulary as required. This
information is captured for naturally derived polymers ( . starch) and
structurally diverse substances. For Organisms belonging to the Kingdom
Plantae the Substance level defines the fresh material of a single species
or infraspecies, the Herbal Drug and the Herbal preparation. For Herbal
preparations, the fraction information will be captured at the Substance
information level and additional information for herbal extracts will be
captured at the Specified Substance Group 1 information level. See for
further explanation the Substance Class: Structurally Diverse and the
herbal annex.
-
SubstanceSourceMaterialPartDescription
-
SubstanceSourceMaterialPartDescription Source material shall capture
information on the taxonomic and anatomical origins as well as the
fraction of a material that can result in or can be modified to form a
substance. This set of data elements shall be used to define polymer
substances isolated from biological matrices. Taxonomic and anatomical
origins shall be described using a controlled vocabulary as required. This
information is captured for naturally derived polymers ( . starch) and
structurally diverse substances. For Organisms belonging to the Kingdom
Plantae the Substance level defines the fresh material of a single species
or infraspecies, the Herbal Drug and the Herbal preparation. For Herbal
preparations, the fraction information will be captured at the Substance
information level and additional information for herbal extracts will be
captured at the Specified Substance Group 1 information level. See for
further explanation the Substance Class: Structurally Diverse and the
herbal annex.